Congress extends voluntary Alzheimer's research stamp for 6 more years
S. 5119 — A bill to require the United States Postal Service to sell the Alzheimer's semipostal stamp for 6 additional years. · Filed by Ed Markey (D-MA) · 13 cosponsors · Introduced Jul 23, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the U.S. Postal Service to continue selling the Alzheimer's semipostal stamp (a special stamp sold at a premium price) for 6 additional years beyond when it would normally expire. The extra revenue from these stamp sales goes to the National Institutes of Health to fund Alzheimer's disease research. Ordinary citizens who want to support Alzheimer's research can do so by buying these stamps instead of regular postage.
Why we flagged it
The bill extends a voluntary semipostal stamp program that allows citizens to contribute to Alzheimer's research through their postal spending. It is a straightforward public-health funding tool with no hidden provisions or narrow beneficiaries.
What the text implies
- The bill does not appropriate new federal funds; it relies entirely on voluntary consumer choice. If stamp sales decline, research funding may fall short of expectations.
- The National Institutes of Health receives the proceeds but the bill does not specify how NIH must allocate or prioritize Alzheimer's research funding, leaving discretion to the agency.
The full analysis lists 3 implications of this text.
Who stands to gain
National Institutes of Health (recipient of research funding)